Related Experiment Video
Updated: Mar 16, 2026
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
Caroline Vieira Spessotto1,2, Hanaie Cavalli3, Audred Cristina Biondo Eboni4
1Universidade Metropolitana de Santos, Departamento de Neurologia, Santos SP, Brasil;
Objective:
The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients' satisfaction with the treatment must be taken into consideration.
Methods:
Individual interview with patients with MS regarding their satisfaction and points of view on the treatment with DMDs.
Results:
One hundred and twenty eight patients attending specialized MS Units in five different cities were interviewed. Over 80% of patients were very satisfied with the drugs in use regarding convenience and perceived benefits. The only aspect scoring lesser values was tolerability.
Conclusion:
Parameters for improving treatment in MS must include efficacy, safety, and patient satisfaction with the given DMD.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
01:28Drug Therapy
Antianxiety Medications